{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:19:45Z","timestamp":1780334385404,"version":"3.54.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT162328"],"award-info":[{"award-number":["PJT162328"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neo.2025.101237","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:43:56Z","timestamp":1759995836000},"page":"101237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["RANKL and CSF-1 are elevated in periovulatory follicular fluid of BRCA1 mutation carriers and increase proinflammatory signaling in fallopian tube epithelial cells"],"prefix":"10.1016","volume":"70","author":[{"given":"Alexandra","family":"Kollara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidushi","family":"Madaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3074-4516","authenticated-orcid":false,"given":"Theodore J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neo.2025.101237_bib0001","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.neo.2025.101237_bib0002","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/GRF.0000000000000313","article-title":"Taking the tube: from normal fallopian tube epithelium to ovarian high-grade serous carcinoma","volume":"60","author":"Tone","year":"2017","journal-title":"Clin. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.neo.2025.101237_bib0003","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.neo.2025.101237_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.32916","article-title":"Prophylactic salpingectomy for the prevention of ovarian cancer: who should we target?","author":"Kotsopoulos","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.neo.2025.101237_bib0005","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.neo.2025.101237_bib0006","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"5645","key":"10.1016\/j.neo.2025.101237_bib0007","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.neo.2025.101237_bib0008","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.neo.2025.101237_bib0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ygyno.2018.05.011","article-title":"Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation","volume":"150","author":"Kotsopoulos","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.neo.2025.101237_bib0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13048-021-00809-w","article-title":"Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing","volume":"14","author":"Cummings","year":"2021","journal-title":"J. Ovarian. Res."},{"issue":"7716","key":"10.1016\/j.neo.2025.101237_bib0011","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2013a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.neo.2025.101237_bib0012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2005.09.014","article-title":"Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses","volume":"247","author":"Fleming","year":"2006","journal-title":"Mol. Cell Endocrinol."},{"issue":"4","key":"10.1016\/j.neo.2025.101237_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040952","article-title":"High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.neo.2025.101237_bib0014","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/er.2018-00075","article-title":"Ovulation: parallels with inflammatory processes","volume":"40","author":"Duffy","year":"2019","journal-title":"Endocr. Rev."},{"issue":"6917","key":"10.1016\/j.neo.2025.101237_bib0015","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neo.2025.101237_bib0016","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/1541-7786.MCR-05-0261","article-title":"Inflammation, a key event in cancer development","volume":"4","author":"Lu","year":"2006","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.neo.2025.101237_bib0017","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1314424","article-title":"Type-I-interferons in infection and cancer: unanticipated dynamics with therapeutic implications","volume":"6","author":"Musella","year":"2017","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.neo.2025.101237_bib0018","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-\u03bab, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"16","key":"10.1016\/j.neo.2025.101237_bib0019","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1158\/1078-0432.CCR-12-0199","article-title":"Prolonged postovulatory proinflammatory signaling in the fallopian tube epithelium may be mediated through a BRCA1\/DAB2 axis","volume":"18","author":"Tone","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.neo.2025.101237_bib0020","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1158\/1078-0432.CCR-07-4959","article-title":"Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma","volume":"14","author":"Tone","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.neo.2025.101237_bib0021","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neo.2018.05.005","article-title":"BRCA1 Mutation status and follicular fluid exposure alters NFkappaB signaling and ISGylation in Human fallopian tube epithelial cells","volume":"20","author":"Hollingsworth","year":"2018","journal-title":"Neoplasia"},{"issue":"7","key":"10.1016\/j.neo.2025.101237_bib0022","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/aje\/kwh284","article-title":"Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations","volume":"160","author":"McGuire","year":"2004","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.neo.2025.101237_bib0023","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1470-2045(06)70983-4","article-title":"Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"8","author":"McLaughlin","year":"2007","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.neo.2025.101237_bib0024","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary ovarian cancer clinical Study Group","volume":"339","author":"Narod","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.neo.2025.101237_bib0025","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00432-020-03377-6","article-title":"Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario","volume":"147","author":"Lerner-Ellis","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.neo.2025.101237_bib0026","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/bib\/bbl016","article-title":"Partial least squares: a versatile tool for the analysis of high-dimensional genomic data","volume":"8","author":"Boulesteix","year":"2007","journal-title":"Brief. Bioinform."},{"issue":"12","key":"10.1016\/j.neo.2025.101237_bib0027","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.190.12.1741","article-title":"Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-fms and receptor activator of nuclear factor kappaB (RANK) receptors","volume":"190","author":"Arai","year":"1999","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.neo.2025.101237_bib0028","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1248\/bpb.b14-00410","article-title":"ISG15 regulates RANKL-induced osteoclastogenic differentiation of RAW264 cells","volume":"38","author":"Takeuchi","year":"2015","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.neo.2025.101237_bib0029","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(01)00599-2","article-title":"IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development","volume":"107","author":"Cao","year":"2001","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.neo.2025.101237_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028081","article-title":"M-CSF induces monocyte survival by activating NF-\u03bab p65 phosphorylation at Ser276 via protein kinase C","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.neo.2025.101237_bib0031","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1016\/S0021-9258(18)42585-9","article-title":"The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins","volume":"267","author":"Loeb","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"30","key":"10.1016\/j.neo.2025.101237_bib0032","doi-asserted-by":"crossref","first-page":"31304","DOI":"10.1074\/jbc.M308975200","article-title":"Role of nuclear factor-kappaB in the antiviral action of interferon and interferon-regulated gene expression","volume":"279","author":"Pfeffer","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.neo.2025.101237_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107686","article-title":"ISGylation enhances dsRNA-induced interferon response and nf\u03bab signaling in fallopian tube epithelial cells","volume":"300","author":"Madaan","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.neo.2025.101237_bib0034","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03bab, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"16","key":"10.1016\/j.neo.2025.101237_bib0035","first-page":"4476","article-title":"Tumor necrosis factor expression by human ovarian carcinoma in vivo","volume":"51","author":"Takeyama","year":"1991","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.neo.2025.101237_bib0036","first-page":"745","article-title":"Distinct expression and localization of TNF system in ovarian carcinoma tissues: possible involvement of TNF-\u03b1 in morphological changes of ovarian cancerous cells","volume":"34","author":"Piura","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.neo.2025.101237_bib0037","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev-pathol-031920-093932","article-title":"Opposing roles of type I interferons in cancer immunity","volume":"16","author":"Boukhaled","year":"2021","journal-title":"Annu Rev. Pathol."},{"issue":"9","key":"10.1016\/j.neo.2025.101237_bib0038","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41590-022-01290-3","article-title":"Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B","volume":"23","author":"Musella","year":"2022","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.neo.2025.101237_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2021.04.022","article-title":"RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness","volume":"56","author":"Ben\u00edtez","year":"2021","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.neo.2025.101237_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.113978","article-title":"RANK\/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-\u03bab pathway","volume":"436","author":"Takeda","year":"2024","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.neo.2025.101237_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020282","article-title":"CSF-1R in cancer: more than a myeloid cell receptor","volume":"16","author":"Cersosimo","year":"2024","journal-title":"Cancers. (Basel)"},{"issue":"47","key":"10.1016\/j.neo.2025.101237_bib0042","doi-asserted-by":"crossref","first-page":"18490","DOI":"10.1073\/pnas.0809242105","article-title":"An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer","volume":"105","author":"Weichselbaum","year":"2008","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"issue":"1","key":"10.1016\/j.neo.2025.101237_bib0043","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.trecan.2022.09.003","article-title":"How cancer cells make and respond to interferon-I","volume":"9","author":"Cheon","year":"2023","journal-title":"Trends. Cancer"},{"issue":"15","key":"10.1016\/j.neo.2025.101237_bib0044","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1038\/s41388-018-0624-2","article-title":"Type I interferon\/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer","volume":"38","author":"Lan","year":"2019","journal-title":"Oncogene"},{"issue":"46","key":"10.1016\/j.neo.2025.101237_bib0045","doi-asserted-by":"crossref","first-page":"14313","DOI":"10.1073\/pnas.1505690112","article-title":"Type I IFN induces protein ISGylation to enhance cytokine expression and augments colonic inflammation","volume":"112","author":"Fan","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"7","key":"10.1016\/j.neo.2025.101237_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022200","article-title":"USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon \u03b1 response","volume":"6","author":"Fran\u00e7ois-Newton","year":"2011","journal-title":"PLoS. One"},{"issue":"12","key":"10.1016\/j.neo.2025.101237_bib0047","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/cr.2016.125","article-title":"USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING\/MITA","volume":"26","author":"Zhang","year":"2016","journal-title":"Cell Res."},{"issue":"6","key":"10.1016\/j.neo.2025.101237_bib0048","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1095\/biolreprod.109.082941","article-title":"Formation of the ovarian follicular antrum and follicular fluid","volume":"82","author":"Rodgers","year":"2010","journal-title":"Biol. Reprod."},{"issue":"11","key":"10.1016\/j.neo.2025.101237_bib0049","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1093\/humrep\/del257","article-title":"Peptide and protein profiles in serum and follicular fluid of women undergoing IVF","volume":"21","author":"Schweigert","year":"2006","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.neo.2025.101237_bib0050","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0015-0282(16)38284-X","article-title":"Immunologic studies on human follicular fluid","volume":"22","author":"Manarang-Pangan","year":"1971","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.neo.2025.101237_bib0051","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0015-0282(16)39730-8","article-title":"Proteins of human follicular fluid: the blood-follicle barrier","volume":"24","author":"Shalgi","year":"1973","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.neo.2025.101237_bib0052","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jprot.2013.05.017","article-title":"Proteomic analysis of human follicular fluid: a new perspective towards understanding folliculogenesis","volume":"87","author":"Ambekar","year":"2013","journal-title":"J. Proteomics."},{"issue":"1","key":"10.1016\/j.neo.2025.101237_bib0053","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/humrep\/14.1.162","article-title":"Cytokines in the follicular fluid of stimulated and non-stimulated human ovaries; is ovulation a suppressed inflammatory reaction?","volume":"14","author":"Buscher","year":"1999","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.neo.2025.101237_bib0054","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.fertnstert.2004.06.072","article-title":"Expression of mRNA and protein of macrophage colony-stimulating factor and its receptor in human follicular luteinized granulosa cells","volume":"83","author":"Salmassi","year":"2005","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.neo.2025.101237_bib0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/jrf.0.1040325","article-title":"Effects of macrophage colony-stimulating factor on folliculogenesis in gonadotrophin-primed immature rats","volume":"104","author":"Nishimura","year":"1995","journal-title":"J. Reprod. Fertil."},{"issue":"2","key":"10.1016\/j.neo.2025.101237_bib0056","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1095\/biolreprod54.2.478","article-title":"Follicular development and ovulation in macrophage colony-stimulating factor-deficient mice homozygous for the osteopetrosis (op) mutation","volume":"54","author":"Araki","year":"1996","journal-title":"Biol. Reprod."},{"issue":"7","key":"10.1016\/j.neo.2025.101237_bib0057","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/humrep\/del065","article-title":"The human cumulus\u2013oocyte complex gene-expression profile","volume":"21","author":"Assou","year":"2006","journal-title":"Hum. Reprod."},{"issue":"11","key":"10.1016\/j.neo.2025.101237_bib0058","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.160230","article-title":"RANKL\/RANK: from bone loss to the prevention of breast cancer","volume":"6","author":"Sigl","year":"2016","journal-title":"Open. Biol."},{"issue":"6","key":"10.1016\/j.neo.2025.101237_bib0059","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060791","article-title":"Clinical impact of RANK signalling in ovarian cancer","volume":"11","author":"Wieser","year":"2019","journal-title":"Cancers. (Basel)"},{"issue":"7299","key":"10.1016\/j.neo.2025.101237_bib0060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature09091","article-title":"Progesterone induces adult mammary stem cell expansion","volume":"465","author":"Joshi","year":"2010","journal-title":"Nature"},{"issue":"7320","key":"10.1016\/j.neo.2025.101237_bib0061","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature09387","article-title":"Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer","volume":"468","author":"Schramek","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neo.2025.101237_bib0062","doi-asserted-by":"crossref","first-page":"e006","DOI":"10.1621\/nrs.04006","article-title":"Regulation of progesterone receptor signaling by BRCA1 in mammary cancer","volume":"4","author":"Katiyar","year":"2006","journal-title":"Nucl. Recept. Signal."},{"issue":"5804","key":"10.1016\/j.neo.2025.101237_bib0063","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1126\/science.1130471","article-title":"Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist","volume":"314","author":"Poole","year":"2006","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.neo.2025.101237_bib0064","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/0008-5472.CAN-04-1283","article-title":"Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers","volume":"64","author":"King","year":"2004","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.neo.2025.101237_bib0065","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S1470-2045(13)70448-0","article-title":"The sex hormone system in carriers of BRCA1\/2 mutations: a case-control study","volume":"14","author":"Widschwendter","year":"2013","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.neo.2025.101237_bib0066","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1200\/JCO.24.00176","article-title":"Hormonal contraception and breast cancer risk for carriers of germline mutations in BRCA1 and BRCA2","volume":"43","author":"Phillips","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.neo.2025.101237_bib0067","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jamaoncol.2018.0211","article-title":"Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers","volume":"4","author":"Kotsopoulos","year":"2018","journal-title":"JAMa Oncol."},{"issue":"8","key":"10.1016\/j.neo.2025.101237_bib0068","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nm.4118","article-title":"RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers","volume":"22","author":"Nolan","year":"2016","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.neo.2025.101237_bib0069","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/cr.2016.69","article-title":"RANKL\/RANK control Brca1 mutation","volume":"26","author":"Sigl","year":"2016","journal-title":"Cell Res."},{"issue":"10","key":"10.1016\/j.neo.2025.101237_bib0070","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.ebiom.2015.08.037","article-title":"Osteoprotegerin (OPG), the endogenous inhibitor of receptor activator of NF-kappaB Ligand (RANKL), is dysregulated in BRCA mutation carriers","volume":"2","author":"Widschwendter","year":"2015","journal-title":"EBioMedicine"},{"issue":"25","key":"10.1016\/j.neo.2025.101237_bib0071","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.18632\/oncotarget.26810","article-title":"Plasma RANKL levels are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers","volume":"10","author":"Zaman","year":"2019","journal-title":"Oncotarget."},{"issue":"1","key":"10.1016\/j.neo.2025.101237_bib0072","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-016-4029-z","article-title":"Can we prevent BRCA1-associated breast cancer by RANKL inhibition?","volume":"161","author":"Kotsopoulos","year":"2017","journal-title":"Breast. Cancer Res. Treat."},{"issue":"52","key":"10.1016\/j.neo.2025.101237_bib0073","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.1038\/sj.onc.1203123","article-title":"CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells","volume":"18","author":"Lee","year":"1999","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.neo.2025.101237_bib0074","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.1158\/0008-5472.CAN-09-1868","article-title":"Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor","volume":"69","author":"Patsialou","year":"2009","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.neo.2025.101237_bib0075","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2217\/fon.09.103","article-title":"Role of CSF-1 in progression of epithelial ovarian cancer","volume":"5","author":"Chambers","year":"2009","journal-title":"Future Oncol."},{"issue":"3","key":"10.1016\/j.neo.2025.101237_bib0076","article-title":"Colony-stimulating factor-1 receptor inhibition combined with paclitaxel exerts effective antitumor effects in the treatment of ovarian cancer","volume":"11","author":"Yu","year":"2024","journal-title":"Genes. Dis."},{"key":"10.1016\/j.neo.2025.101237_bib0077","doi-asserted-by":"crossref","first-page":"509","DOI":"10.12688\/f1000research.53364.1","article-title":"Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden","volume":"10","author":"Ren","year":"2021","journal-title":"F1000Res."},{"issue":"43","key":"10.1016\/j.neo.2025.101237_bib0078","doi-asserted-by":"crossref","first-page":"31601","DOI":"10.1074\/jbc.M706078200","article-title":"Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways","volume":"282","author":"Vitovski","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neo.2025.101237_bib0079","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1757-2215-5-34","article-title":"Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis","volume":"5","author":"Lane","year":"2012","journal-title":"J. Ovarian. Res."},{"key":"10.1016\/j.neo.2025.101237_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.654940","article-title":"Salubrinal exposes anticancer properties in inflammatory breast cancer cells by manipulating the endoplasmic reticulum stress pathway","volume":"11","author":"Alsterda","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.neo.2025.101237_bib0081","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/humrep\/deae003","article-title":"The intrafollicular concentrations of biologically active cortisol in women rise abruptly shortly before ovulation and follicular rupture","volume":"39","author":"Johannsen","year":"2024","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.neo.2025.101237_bib0082","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/1535370213508216","article-title":"Altered expression of inflammation-associated genes in oviductal cells following follicular fluid exposure: implications for ovarian carcinogenesis","volume":"239","author":"Lau","year":"2014","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"4","key":"10.1016\/j.neo.2025.101237_bib0083","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/aja.1001560405","article-title":"Cyclic changes in ciliation, secretion and cell height of the oviductal epithelium in women","volume":"156","author":"Verhage","year":"1979","journal-title":"Am. J. Anat."},{"issue":"13","key":"10.1016\/j.neo.2025.101237_bib0084","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.7150\/jca.30588","article-title":"Estradiol and progesterone induced differentiation and increased stemness gene expression of Human fallopian tube epithelial cells","volume":"10","author":"Chang","year":"2019","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.neo.2025.101237_bib0085","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/carcin\/bgz127","article-title":"Reduced PAX2 expression in murine fallopian tube cells enhances estrogen receptor signaling","volume":"41","author":"Colina","year":"2020","journal-title":"Carcinogenesis"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625001174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625001174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:37:37Z","timestamp":1773157057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625001174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":85,"alternative-id":["S1476558625001174"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101237","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RANKL and CSF-1 are elevated in periovulatory follicular fluid of BRCA1 mutation carriers and increase proinflammatory signaling in fallopian tube epithelial cells","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. CCBYLICENSE","name":"copyright","label":"Copyright"}],"article-number":"101237"}}